SCHEMBL867968

SCHEMBL867968

CC1CNC(=O)C(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29332611 1.00
SCHEMBL22175597 0.95 CRBN (0.31)
SCHEMBL20841336 0.81
SCHEMBL5077969 0.81
SCHEMBL24619019 0.81
SCHEMBL7624170 0.78 CRBN (0.32)
SCHEMBL20798638 0.76 L3MBTL1 (0.32)
SCHEMBL25838012 0.76
SCHEMBL2080528 0.76
SCHEMBL25838036 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077717-A1 Polymers Having N-Vinyl Amide And Hydroxyl Moieties, Their Compositions And The Uses Thereof ISP INVESTMENTS INC. (US) 2012-03-29 US claimed
US-20080182773-A1 Thickeners Based on Polymers Comprising Amine Groups BASF AKTIENGESELLSCHAFT (DE) 2008-07-31 US claimed
EP-1863574-A1 THICKENER BASED ON AMINE GROUP-CONTAINING POLYMERS BASF AKTIENGESELLSCHAFT (DE) 2007-12-12 EP claimed
WO-2006100299-A1 THICKENER BASED ON AMINE GROUP-CONTAINING POLYMERS BASF AKTIENGESELLSCHAFT (DE) 2006-09-28 WO claimed
US-20260078117-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS INC (US) 2026-03-19 US disclosed
US-12304907-B2 Compounds and methods of use TANGO THERAPEUTICS, INC. (US) 2025-05-20 US disclosed
US-12264154-B2 Compounds and methods of use TANGO THERAPEUTICS, INC. (US) 2025-04-01 US disclosed
US-20240279219-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-08-22 US disclosed
US-20240228478-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-07-11 US disclosed
US-20240228478-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-07-11 US disclosed
US-20240228478-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-07-11 US disclosed
US-11999727-B2 Compounds and methods of use TANGO THERAPEUTICS, INC. (US) 2024-06-04 US disclosed
CN-1413191-A Method for production of N-alkenyl amides BASF AG (DE) 2003-04-23 CN disclosed
CN-1411443-A Method for producing N-alkenyl amides BASF AG (DE) 2003-04-16 CN disclosed
US-20030036659-A1 Method for the production of n-alkenyl amides BASF AKTIENGESELLSCHAFT (DE) 2003-02-20 US disclosed
US-20030028035-A1 Method for producing n-alkenyl amides BASF AKTIENGESELLSCHAFT (DE) 2003-02-06 US disclosed
EP-1240139-A1 METHOD FOR PRODUCING N-ALKENYL AMIDES BASF AKTIENGESELLSCHAFT (DE) 2002-09-18 EP disclosed
WO-2001046139-A1 METHOD FOR PRODUCING N-ALKENYL AMIDES BASF AKTIENGESELLSCHAFT (DE) 2001-06-28 WO disclosed
US-5629322-A TREATMENT OF NEURODEGENERATIVE DISORDERS, DISORDERS OF GASTROINTESTINAL MOTILITY AND INFLAMMATION MERCK & CO., INC. (US) 1997-05-13 US disclosed
WO-1996014844-A1 CYCLIC AMIDINE ANALOGS AS INHIBITORS OF NITRIC OXIDE SYNTHASE MERCK & CO., INC. (US) 1996-05-23 WO disclosed